Picture of Ardelyx logo

ARDX — Ardelyx News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapSucker Stock

Brief: Ardelyx Says FDA Approves Xphozah, A First-In-Class Phosphate Absorption Inhibitor

Oct 17 (Reuters) - Ardelyx Inc  ARDX.O :
    * FDA APPROVES XPHOZAH® (TENAPANOR), A FIRST-IN-CLASS
PHOSPHATE
ABSORPTION INHIBITOR
    * COMMERCIAL LAUNCH UNDERWAY WITH PRODUCT EXPECTED TO BE
AVAILABLE
IN NOVEMBER

Source text for Eikon:  ID:nGNX4pJWxv 
Further company coverage:  ARDX.O 

 ((reuters.briefs@thomsonreuters.com;))

Recent news on Ardelyx

See all news